申请人:Hoffmann-La Roche Inc.
公开号:US04513002A1
公开(公告)日:1985-04-23
1-[2-(4,5,10,11-Tetrahydro-1H-dibenzo[a,d]cyclohepten-5-yl)ethyl]pyrrolidin e of the formula ##STR1## and its pharmaceutically acceptable acid addition salts, prepared through various intermediates, are described. The compounds have valuable histamine-H.sub.1 antagonistic properties and are suitable for the control or prevention of allergic reactions, such as, urticaria, hay fever, anaphylaxis and over-sensitivity to medicaments.
描述了一种化合物1-[2-(4,5,10,11-四氢-1H-二苯并[a,d]环庚烯-5-基)乙基]吡咯烷及其药学上可接受的酸盐加合物,该化合物通过各种中间体制备。该化合物具有有价值的组胺H.sub.1拮抗作用,适用于控制或预防过敏反应,例如荨麻疹、花粉热、过敏性休克和对药物过敏等。